2013 Journal Article Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune diseaseAbd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8 |
2013 Journal Article Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, CanadaTett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442 |
2011 Journal Article Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000 |
2011 Journal Article Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposureTett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001 |
2011 Journal Article How is medication prescribing ceased? A systematic reviewOstini, Remo, Jackson, Claire, Hegney, Desley and Tett, Susan E. (2011). How is medication prescribing ceased? A systematic review. Medical Care, 49 (1), 24-36. doi: 10.1097/MLR.0b013e3181ef9a7e |
2009 Journal Article Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribingBarozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012 |
2009 Journal Article The Australian rise of esomeprazole-was expenditure on samples a contributor?Kyle, G. J., Nissen, L. M. and Tett, S. E. (2009). The Australian rise of esomeprazole-was expenditure on samples a contributor?. Pharmacoepidemiology and Drug Safety, 18 (1), 62-68. doi: 10.1002/pds.1685 |
2008 Journal Article Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel useOstini, R., Hegney, D., Mackson, J. M., Williamson, M and Tett, S.E. (2008). Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and Drug Safety, 17 (11), 1077-1090. doi: 10.1002/pds.1638 |
2008 Journal Article A comparison of benzodiazepine and related drug use in Nova Scotia and AustraliaSmith, Alesha J., Sketris, Ingrid, Cooke, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. The Canadian Journal of Psychiatry, 53 (8), 545-552. doi: 10.1177/070674370805300809 |
2020 Journal Article Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipientsBrooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2020). Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients. Therapeutic Drug Monitoring, 43 (2), 238-246. doi: 10.1097/ftd.0000000000000814 |
2019 Journal Article Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipientsBrooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clinical Drug Investigation, 39 (12), 1175-1184. doi: 10.1007/s40261-019-00844-y |
2019 Journal Article Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipientsBrooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients. Therapeutic Drug Monitoring, 41 (6), 755-760. doi: 10.1097/FTD.0000000000000687 |
2019 Conference Publication Saliva prednisolone measurements in adult kidney transplant recipientsStaatz, C. E., Tett, S. E., Isbel, N., Mc Whinney, B. and Brooks, E. (2019). Saliva prednisolone measurements in adult kidney transplant recipients. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Foz de Iguassu, Brazil, September 2019. |
2018 Journal Article Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8 |
2018 Journal Article Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reportsJones, Mark, Tett, Susan E. and Del Mar, Chris (2018). Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports. Pharmacoepidemiology and Drug Safety, 27 (11), 1217-1222. doi: 10.1002/pds.4651 |
2018 Journal Article Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant RecipientsBrooks, Emily K, Staatz, Christine E, Tett, Susan E, Isbel, Nicole M and McWhinney, Brett (2018). Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring, 40 (2), 195-201. doi: 10.1097/FTD.0000000000000486 |
2018 Conference Publication Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.. International Association of Therapeutic Drug Monitoring and Clinical Toxicology Brisbane, Brisbane, QLD Australia, 16-19 September 2018. |
2018 Conference Publication Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.. American Transplant Congress, Seattle, WA United States, 2-6 June 2018. Hoboken, NJ United States: Wiley. |
2018 Conference Publication Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisoloneBrooks, E., Tett, S. E., Isbel, N. and Staatz, C. E. (2018). Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone. RACP Trainee Research Awards, Brisbane, QLD Australia, 7 November 2018. |
2017 Journal Article Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus NephritisAbd Rahman, Azrin N, Tett, Susan E, Abdul Gafor, Halim A, McWhinney, Brett C and Staatz, Christine E (2017). Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis. European journal of drug metabolism and pharmacokinetics, 42 (6), 993-1004. doi: 10.1007/s13318-017-0420-3 |